Commonwealth of Pennsylvania Public School Empls Retrmt SYS Has $1.62 Million Stake in Masimo Co. (NASDAQ:MASI)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its position in Masimo Co. (NASDAQ:MASI) by 0.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,815 shares of the medical equipment provider’s stock after purchasing an additional 82 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS’s holdings in Masimo were worth $1,622,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. National Bank of Canada FI increased its stake in Masimo by 195.6% in the 3rd quarter. National Bank of Canada FI now owns 132,500 shares of the medical equipment provider’s stock valued at $17,666,000 after buying an additional 87,675 shares during the last quarter. Lecap Asset Management Ltd. bought a new position in shares of Masimo in the 4th quarter valued at about $1,607,000. Nisa Investment Advisors LLC increased its position in shares of Masimo by 16,740.0% in the fourth quarter. Nisa Investment Advisors LLC now owns 5,052 shares of the medical equipment provider’s stock valued at $835,000 after acquiring an additional 5,022 shares during the last quarter. Trust Point Inc. bought a new stake in Masimo during the fourth quarter worth about $230,000. Finally, Barclays PLC boosted its position in Masimo by 152.6% during the third quarter. Barclays PLC now owns 39,957 shares of the medical equipment provider’s stock valued at $5,329,000 after purchasing an additional 24,137 shares during the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.

Masimo Price Performance

NASDAQ:MASI opened at $169.70 on Wednesday. The company has a market cap of $9.16 billion, a P/E ratio of 117.03 and a beta of 1.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.01 and a quick ratio of 1.11. The firm’s fifty day moving average price is $175.10 and its two-hundred day moving average price is $160.61. Masimo Co. has a one year low of $101.61 and a one year high of $194.88.

Masimo (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, February 25th. The medical equipment provider reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.38. Masimo had a net margin of 3.85% and a return on equity of 14.98%. The firm had revenue of $600.70 million during the quarter, compared to the consensus estimate of $593.35 million. Equities analysts expect that Masimo Co. will post 4.1 earnings per share for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on MASI. Wells Fargo & Company boosted their price target on Masimo from $193.00 to $205.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Raymond James boosted their target price on shares of Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a report on Friday, December 27th. Piper Sandler increased their price target on shares of Masimo from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Wednesday, February 26th. Finally, Needham & Company LLC restated a “hold” rating on shares of Masimo in a research note on Wednesday, February 26th. Two analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $194.80.

Insider Buying and Selling at Masimo

In other news, COO Bilal Muhsin sold 30,000 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.49, for a total value of $5,024,700.00. Following the completion of the sale, the chief operating officer now owns 24,172 shares of the company’s stock, valued at approximately $4,048,568.28. The trade was a 55.38 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Craig B. Reynolds sold 2,053 shares of the firm’s stock in a transaction dated Friday, March 14th. The stock was sold at an average price of $166.13, for a total transaction of $341,064.89. Following the transaction, the director now directly owns 16,581 shares in the company, valued at approximately $2,754,601.53. This represents a 11.02 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 9.70% of the company’s stock.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.